Advertisement

Long-term response to pazopanib in an elderly man with mRCC. A case report

Abstract

In recent years, the therapeutic scenario of metastatic renal cell carcinoma (mRCC) has been enriched by several new drugs that have revolutionized the natural history of this cancer. Pazopanib, an oral angiogenesis inhibitor, was recently approved for first-line and post-cytokine treatment of mRCC. The choice of the best first-line medical therapy is now the main clinical problem to be addressed. The decision-making is influenced by various factors: the results of pivotal trials including published faceto-face studies, the patient’s medical history, and the safety profile of the drug. We present a case report of a long-surviving elderly man with mRCC who did not undergo a cytoreductive nephrectomy and was treated with pazopanib.

Tumori 2014; 100(6): e305 - e308

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1778.19308

Authors

Carmine D’Aniello, Carla Cavaliere, Salvatore Pisconti, Gaetano Facchini

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • D’Aniello, Carmine [PubMed] [Google Scholar]
    Department of Oncology and Hematology, Medical Oncology Unit, SG Moscati Hospital, Taranto, Italy
  • Cavaliere, Carla [PubMed] [Google Scholar]
    Department of Oncology and Hematology, Medical Oncology Unit, SG Moscati Hospital, Taranto, Italy
  • Pisconti, Salvatore [PubMed] [Google Scholar]
    Department of Oncology and Hematology, Medical Oncology Unit, SG Moscati Hospital, Taranto, Italy
  • Facchini, Gaetano [PubMed] [Google Scholar]
    Department of Urology and Gynecology, Medical Oncology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS Fondazione Giovanni Pascale, Naples, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.